1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Urinary Tract Cancer Global Clinical Trials Review, H1, 2014

Urinary Tract Cancer Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Urinary Tract Cancer Global Clinical Trials Review, H1, 2014" provides data on the Urinary Tract Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Urinary Tract Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Urinary Tract Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Urinary Tract Cancer Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Urinary Tract Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Urinary Tract Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Urinary Tract Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Urinary Tract Cancer 25
Subjects Recruited Over a Period of Time 42
Clinical Trials by Sponsor Type 43
Prominent Sponsors 44
Top Companies Participating in Urinary Tract Cancer Therapeutics Clinical Trials 45
Prominent Drugs 46
Clinical Trial Profiles 47
Clinical Trial Overview of Top Companies 47
Pfizer Inc. 47
Clinical Trial Overview of Pfizer Inc. 47
Novartis AG 54
Clinical Trial Overview of Novartis AG 54
Bayer AG 59
Clinical Trial Overview of Bayer AG 59
GlaxoSmithKline plc 63
Clinical Trial Overview of GlaxoSmithKline plc 63
F. Hoffmann-La Roche Ltd. 67
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 67
Eli Lilly and Company 71
Clinical Trial Overview of Eli Lilly and Company 71
Bristol-Myers Squibb Company 74
Clinical Trial Overview of Bristol-Myers Squibb Company 74
AstraZeneca PLC 76
Clinical Trial Overview of AstraZeneca PLC 76
Merck and Co., Inc. 78
Clinical Trial Overview of Merck and Co., Inc. 78
Amgen Inc. 80
Clinical Trial Overview of Amgen Inc. 80
Clinical Trial Overview of Top Institutes / Government 82
National Cancer Institute 82
Clinical Trial Overview of National Cancer Institute 82
Memorial Sloan Kettering Cancer Center 105
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 105
The University of Texas M. D. Anderson Cancer Center 110
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 110
European Organization for Research and Treatment of Cancer 114
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 114
Children's Oncology Group 118
Clinical Trial Overview of Children's Oncology Group 118
UCLA's Jonsson Comprehensive Cancer Center 120
Clinical Trial Overview of UCLA's Jonsson Comprehensive Cancer Center 120
The University of Chicago 122
Clinical Trial Overview of The University of Chicago 122
Southwest Oncology Group 124
Clinical Trial Overview of Southwest Oncology Group 124
Case Comprehensive Cancer Center 126
Clinical Trial Overview of Case Comprehensive Cancer Center 126
Eastern Cooperative Oncology Group 127
Clinical Trial Overview of Eastern Cooperative Oncology Group 127
Five Key Clinical Profiles 129
Appendix 224
Abbreviations 224
Definitions 224
Research Methodology 225
Secondary Research 225
About GlobalData 226
Contact Us 226
Disclaimer 226
Source 227

List of Tables
Urinary Tract Cancer Therapeutics, Global, Clinical Trials by Region, 2014* 7
Urinary Tract Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Urinary Tract Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Urinary Tract Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Urinary Tract Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Urinary Tract Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Urinary Tract Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Urinary Tract Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Urinary Tract Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Urinary Tract Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Urinary Tract Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Urinary Tract Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Urinary Tract Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Urinary Tract Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Urinary Tract Cancer Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Urinary Tract Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Urinary Tract Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Urinary Tract Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Urinary Tract Cancer Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Urinary Tract Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2014* 27
Urinary Tract Cancer Therapeutics, Global, Terminated Clinical Trials, 2014* 30
Urinary Tract Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 42
Urinary Tract Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 43
Urinary Tract Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 44
Urinary Tract Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 45
Urinary Tract Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 46
Urinary Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 47
Urinary Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 54
Urinary Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 59
Urinary Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 63
Urinary Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 67
Urinary Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 71
Urinary Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 74
Urinary Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 76
Urinary Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2014* 78
Urinary Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 80
Urinary Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 82
Urinary Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 105
Urinary Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 110
Urinary Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014* 114
Urinary Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2014* 118
Urinary Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by UCLA's Jonsson Comprehensive Cancer Center, 2014* 120
Urinary Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2014* 122
Urinary Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2014* 124
Urinary Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2014* 126
Urinary Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Cooperative Oncology Group, 2014* 127

List of Figures
Urinary Tract Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Urinary Tract Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Urinary Tract Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Urinary Tract Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Urinary Tract Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Urinary Tract Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Urinary Tract Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Urinary Tract Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Urinary Tract Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Urinary Tract Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Urinary Tract Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Urinary Tract Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Urinary Tract Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Urinary Tract Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Urinary Tract Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Urinary Tract Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Urinary Tract Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Urinary Tract Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Urinary Tract Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 42
Urinary Tract Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 43
Urinary Tract Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 44
Urinary Tract Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 45
Urinary Tract Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 46
GlobalData Methodology 225

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Hematological Cancers: Analytical Tool

Hematological Cancers: Analytical Tool

  • $ 11505
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Summary Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is ...

Lung Cancer: Analytical Tool

Lung Cancer: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Ovarian Cancer: Analytical Tool

August 2016 $ 8096

Renal Cancer: Analytical Tool

August 2016 $ 8096

Bladder Cancer: Analytical Tool

August 2016 $ 8096

Brain Cancer: Analytical Tool

August 2016 $ 8096

Breast Cancer: Analytical Tool

August 2016 $ 8096

Download Unlimited Documents from Trusted Public Sources

Cancer Statistics in the US and South Korea

  • November 2016
    2 pages
  • Cancer  

  • United States  

    South Korea  

View report >

Therapy Market in the UK

  • November 2016
    11 pages
  • Therapy  

  • United Kingdom  

View report >

Cancer and Breast Cancer Statistics in the US

  • November 2016
    9 pages
  • Cancer  

    Breast Cancer  

    Cytokine  

  • United States  

View report >

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.